NCT00333034View on ClinicalTrials.gov

Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

May 31, 2007

Conditions

Psoriasis

Interventions

DRUG

Etanercept

Trial Locations (23)

1070

Brussels

3000

Leuven

3501

Miskolc

5400

Szolnok

6020

Innsbruck

6525

Nijmegen

11461

Bucharest

15006

A Coruña

20354

Hamburg

28100

Novara

28922

Madrid

41003

Seville

48149

Münster

53105

Bonn

75010

Paris

75018

Paris

80335

München

93053

Regensburg

98158

Messina

400006

Cluj-Napoca

9202 NN

Drachten

91-347

Lodz

50-368

Wroclaw

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY